0001493152-23-045353.txt : 20231219 0001493152-23-045353.hdr.sgml : 20231219 20231219080006 ACCESSION NUMBER: 0001493152-23-045353 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231219 DATE AS OF CHANGE: 20231219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENETIC TECHNOLOGIES LTD CENTRAL INDEX KEY: 0001166272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51504 FILM NUMBER: 231495657 BUSINESS ADDRESS: STREET 1: 60-66 HANOVER STREET CITY: FITZROY, VICTORIA STATE: C3 ZIP: 3065 BUSINESS PHONE: 011613-9415-1135 MAIL ADDRESS: STREET 1: 60-66 HANOVER STREET CITY: FITZROY, VICTORIA STATE: C3 ZIP: 3065 6-K 1 form6-k.htm

 

 

 

FORM 6-K

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

dated December 19, 2023

 

Commission File Number 0-51504

 

GENETIC TECHNOLOGIES LIMITED

(Exact Name as Specified in its Charter)

 

N/A

(Translation of Registrant’s Name)

 

60-66 Hanover Street

Fitzroy

Victoria 3065 Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes No

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: December 19, 2023

 

  GENETIC TECHNOLOGIES LIMITED
   
  By: /s/ Tony Di Pietro
  Name: Tony Di Pietro
  Title: Company Secretary

 

2
 

 

EXHIBIT INDEX

 

Exhibit   Description of Exhibit
     
99.1   Receipt of R&D Tax Incentive Refund

 

3

 

 

EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

ASX Market Announcement

 

Receipt of R&D Tax Incentive Refund

 

Melbourne, Australia, 18 December 2023: Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to advise that the Company has received $1.75m from the federal government’s Research and Development (R&D) Tax Incentive program for the 2023 financial year.

 

The amount received represents 43.5% of the Company’s eligible R&D expenditure for the 2023 financial year.

 

-END-

 

Authorised for release by the board of directors of Genetic Technologies Limited.

 

Enquiries

 

Investor Relations

Adrian Mulcahy

Automic Markets

M: +61 438 630 411

E: adrian.mulcahy@automicgroup.com.au

 

About Genetic Technologies Limited

 

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. For more information, please visit www.genetype.com

 

Genetic Technologies Limited

www.genetype.com

info@gtglabs.com

ABN 17 009 212 328

60-66 Hanover Street

Fitzroy Victoria 3065

Australia

+61 3 8412 7000

 

 

 

 

GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end